Haemoglobin Glycosilate as a Glycemic Control at Type 2 Diabetes
Mellitus Patients
Rusdiana
1 *
, Maya Savira
2
, Sry Suryani Widjaja
1
1
Departement of Biochemistry, Medical Faculty of Universitas Sumatera Utara, Jl. dr. Mansur, Universitas Sumatera
Utara, Medan, 20155
2
Departement of Physiology, Medical Faculty of Universitas Sumatera Utara, Jl. dr. Mansur, Universitas Sumatera Utara,
Medan, 20155
Keywords: Diabetes Mellitus Type 2, Fasting Blood Sugar, Haemoglobin Glycosylate.
Abstract: Chronic disease that characterized by blood glucose levels that exceed normal values is Diabetes Mellitus.
The patient of type 2 diabetes mellitus must controlled their bood sugar level and the most accurate way to
determine blood sugar levels over the past to three months by Hba1c measurement.This study was to
determine the levels of blood sugar and Hba1c in patients with type 2 diabetes mellitus in Johor Primary
Health Care (PHC) in Medan of Sumatera Utara, Indonesia. This study used cross-sectional design conducted
in Johor PHC, Medan of Sumatera Utara, 40 patients with type 2 diabetes mellitus. All the samples of fasting
blood sugar and HbA1c were recorded for each patient who attend to the PHC . We collected the primary data
through interviews, physical examination and laboratory test. More than half of the samples of this study
have bad Hba1c levels (>8% ) cause of many patients of type 2 diabetes mellitus lack of knowledge about
the correct management of diabetes mellitus.
1 INTRODUCTION
One of the public health problem and a major clinical
is Diabetes mellitus, taht requires continuing medical
care and ingoing patient management education and
support to prevent acute complication and to reduce
the risk long-term complication. All over the world
the precalence of type 2 diabetes mellitus id rapidly
increasing. In 2011, the global prevalence of diabetes
was 366 million and caused 4.6 million deaths (IDF).
This figure is expected to rise to 522 million by 2030
and will be 7th leading cause of death in 2030 (IDF
2012, WHO 2011). Indonesia is the world’s fourth
most populated country, has the seventh largest
number of diabetic patients(7.6 million), despite
relatively low prevalence (4,8% including both
diabetes type 1 and 2 in individuals aged 20-79 years)
in 2012 (IDF, 2012). Because of its high morbidity
and mortality diabetes mellitus is an important health
problem (King H et al, 1998), Indonesia is the country
with the largest numbers of people with diabetes
(Shaw JE,2010, Wild et al, 2004). In urban Indonesia
of the prevalence of diabetes mellitus is 5.7%
(Mihardja L et al, 2009), and a younger age of the
incidence of diabetes mellitus is starting to rise (Chan
JC et al, 2009).
According American Diabetis Association(ADA)
glycemic control as one of the important strategies for
the management of DM and glycosylated
haemoglobin (Hbalc) is the best measure of glycemic
level over the previous 3 months. Hbalc is udes to
monitor diabetic treatment each 3 months once
because of the erythrocyte haemoglobinglycation
since erythrocytes have about 120 days life span, and
reflects overall blood glucose levels over a period 2-
3 months and further, in the achievement of the best
possible glycemic control it has been recognized that
hbalc as an essential adjunct to regular self-blood
glucose measurement assisting (Saudek CD et al,
2009). The health of individuals and communities
depended many factors which was influenced. The
low education level is one of these factors which is
linked poor health, more stress and lower self-
confidence. This aim of study to determine the levels
of Hbalc in patients with type 2 diabetes mellitus in
Johor PHC in Medan of North Sumatera, Indonesia.
2 MATERIAL AND METHODS
Patients were recruited from Medan Johor Primary
Health Care (PHC),North Sumatera, Indonesia.This